<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url>
  <loc>https://webnewsinsider.com/three-antidepressants-outperform-fluoxetine-in-major-long-term-effectiveness-study/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-17T01:12:36+08:00</news:publication_date>
    <news:title>Three Antidepressants Outperform Fluoxetine in Major Long-Term Effectiveness Study</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/why-broad-ras-targeting-drugs-mark-a-turning-point-in-treating-pancreatic-cancer/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-17T00:11:47+08:00</news:publication_date>
    <news:title>Why Broad RAS-Targeting Drugs Mark a Turning Point in Treating Pancreatic Cancer</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/how-at-home-igalmi-differs-from-traditional-treatments-for-schizophrenia-and-bipolar-agitation/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-16T19:12:32+08:00</news:publication_date>
    <news:title>How At-Home Igalmi Differs From Traditional Treatments for Schizophrenia and Bipolar Agitation</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/boron-neutron-capture-therapy-faces-us-coverage-hurdles-over-cost-and-data-gaps/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-16T08:11:08+08:00</news:publication_date>
    <news:title>Boron Neutron Capture Therapy Faces US Coverage Hurdles Over Cost and Data Gaps</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/fda-proposes-slashing-companion-diagnostic-fees-from-636732-to-28653/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-16T06:21:56+08:00</news:publication_date>
    <news:title>FDA Proposes Slashing Companion Diagnostic Fees From $636,732 to $28,653</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/biocons-pebrilzo-fda-approval-cements-its-role-in-affordable-cancer-care/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-16T06:20:52+08:00</news:publication_date>
    <news:title>Biocon&#8217;s Pebrilzo FDA Approval Cements Its Role in Affordable Cancer Care</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/apple-launches-200000-person-study-to-test-how-people-use-ai-for-health-questions/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-16T03:11:39+08:00</news:publication_date>
    <news:title>Apple Launches 200,000-Person Study to Test How People Use AI for Health Questions</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/how-ivonescimab-combines-dual-pathways-to-target-and-fight-tumors/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-16T01:13:05+08:00</news:publication_date>
    <news:title>How Ivonescimab Combines Dual Pathways to Target and Fight Tumors</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/navigating-7-mortgage-rates-strategies-for-buying-a-home-now/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-15T19:11:23+08:00</news:publication_date>
    <news:title>Navigating 7% Mortgage Rates: Strategies for Buying a Home Now</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/how-major-medical-centers-partner-with-tech-firms-for-next-gen-proton-therapy/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-15T17:12:33+08:00</news:publication_date>
    <news:title>How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/fda-denies-approval-for-summit-therapeutics-ivonescimab-in-lung-cancer/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-15T16:15:32+08:00</news:publication_date>
    <news:title>FDA Denies Approval for Summit Therapeutics&#8217; Ivonescimab in Lung Cancer</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/how-will-the-next-era-of-precision-thoracic-oncology-change-treatment-choices-for-lung-cancer-patients/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-15T14:11:05+08:00</news:publication_date>
    <news:title>How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/fda-approval-moves-astellas-padcev-into-curative-bladder-cancer-setting/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-15T09:21:44+08:00</news:publication_date>
    <news:title>FDA Approval Moves Astellas&#8217; Padcev Into Curative Bladder Cancer Setting</news:title>
  </news:news>
</url>
</urlset>